Short Term Choline and Cardiovascular Health

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 8, 2019

Primary Completion Date

December 2, 2022

Study Completion Date

November 21, 2023

Conditions
Cardiovascular Risk Factor
Interventions
DIETARY_SUPPLEMENT

Choline

Participants will consume 1000 mg (2x500 mg) of choline bitartrate (over-the-counter supplement) for 28 consecutive days. At baseline, some participants will also be randomly assigned to consume 1000 mg of choline bitartrate the evening before the third testing session to study its acute effects.

DIETARY_SUPPLEMENT

Placebo

Participants will consume 1000 mg (2x500 mg) of placebo for 28 consecutive days. At baseline, some participants will also be randomly assigned to consume 1000 mg of placebo the evening before the third testing session to study its acute effects.

Trial Locations (1)

24061

Virginia Polytechnic and State University, Blacksburg

All Listed Sponsors
lead

Virginia Polytechnic Institute and State University

OTHER

NCT03327805 - Short Term Choline and Cardiovascular Health | Biotech Hunter | Biotech Hunter